EU Biocides Regulations 2026: BPR Compliance, Article 95, Treated Articles And Review Programme

What the EU Biocidal Products Regulation Means for Manufacturers, Importers, Suppliers and Product Compliance

The EU Biocidal Products Regulation (BPR), Regulation (EU) No 528/2012, establishes the framework for placing biocidal products on the European Economic Area market and for controlling active substances, biocidal products and certain treated articles.

For companies operating in the biocides sector, compliance involves more than checking whether an active substance is approved. Businesses may also need to assess the applicable Product Type (PT), active-substance status, product authorization, Article 95 supplier status, labelling, treated-article requirements and national market obligations.

The BPR covers 22 Product Types across four main groups, including disinfectants, preservatives, pest-control products and other specialist biocidal products. European Chemicals Agency

Companies placing biocidal products on the EU/EEA market should therefore maintain a structured regulatory assessment covering:

• Active substance approval status
• Product Type classification
• Product authorization
• Article 95 supplier status
• Review Programme status
• Treated-article requirements
• Labelling and claims
• National market requirements
• Supplier and formulation controls
• Regulatory change management

Why EU Biocides Regulation Matters

Biocidal products are used to control harmful organisms through chemical or biological means and are present across a wide range of commercial and industrial applications.

Examples include:

• Disinfectants
• Preservatives
• Rodenticides
• Insecticides
• Wood preservatives
• Antifouling products
• In-can preservatives
• Film preservatives
• Fiber and textile preservatives
• Construction-material preservatives
• Products used in industrial hygiene

The BPR is designed to ensure that biocidal products can be made available on the market only when their active substances and products satisfy the applicable regulatory requirements. European Chemicals Agency

For manufacturers and suppliers, this creates a compliance chain extending from the active substance through the formulated product and ultimately to the marketed product and its intended use.

What Does the EU Biocidal Products Regulation Cover?

The BPR covers:

• Active substances
• Biocidal products
• Active substances generated in situ
• Products containing or generating active substances
• Certain treated articles
• Substance and product suppliers
• Manufacturers and importers
• Product authorization holders
• Distributors and downstream users

ECHA identifies 22 Product Types under the BPR, divided into four major groups: disinfectants, preservatives, pest-control products and other specialist biocidal products.

Companies should determine the correct active substance/Product Type combination before assessing the regulatory route.

Active Substance Approval Under the BPR

A central requirement of the BPR is the regulatory status of the active substance.

Active substances generally need to be approved for the relevant Product Type before a biocidal product containing that substance can obtain authorization. The evaluation is conducted through the EU regulatory framework, with competent Member State authorities, ECHA's Biocidal Products Committee and the European Commission playing defined roles. European Chemicals Agency

Companies should therefore verify:

• Active substance identity
• CAS and EC numbers where applicable
• Product Type
• Approval status
• Approval expiry date
• Conditions of approval
• Whether the substance is a candidate for substitution
• Whether the substance is under the Review Programme
• Whether the intended use is covered

An active substance should not be assessed independently from its Product Type and intended use.

What Is Article 95 List?

Article 95 list of active substances and suppliers is one of the most important compliance checks for businesses placing biocidal products on the EU market.

Under Article 95, a biocidal product cannot generally be made available on the EU market where the relevant substance or product supplier is not included on the Article 95 list for the applicable Product Type.

Companies should therefore verify:

• Active substance
• Product Type
• Substance supplier
• Product supplier
• Article 95 listing status
• Applicable supplier relationship
• Evidence supporting the supply chain

This assessment should be carried out before commercial launch rather than after a product has already entered the market.

What Are Treated Articles?

A treated article is an article that has been treated with, or intentionally incorporates, one or more biocidal products but does not itself have a primary biocidal function.

Examples can include certain:

• Textiles
• Furniture
• Plastics
• Construction materials
• Consumer articles
• Finished products incorporating preservative treatments

Under the BPR, treated articles are subject to specific requirements concerning the active substances used in their treatment. ECHA states that articles can only be treated with biocidal products containing active substances that are approved in the EU, subject to applicable transitional provisions.

Manufacturers and importers may also have labelling and consumer-information obligations.

Where a consumer requests information about the biocidal treatment of a treated article, the supplier must provide the relevant information free of charge within 45 days.

Key Biocides Compliance Areas

What Products Are Covered by the BPR?

The BPR divides biocidal products into 22 Product Types.

Broadly, these include:

Disinfectants

• Human hygiene
• Private/public health disinfectants
• Veterinary hygiene
• Food and feed area disinfectants
• Drinking water disinfectants

Preservatives

• In-can preservatives
• Film preservatives
• Fiber, leather and rubber preservatives
• Construction-material preservatives
• Wood preservatives

Pest Control

• Rodenticides
• Avicides
• Molluscicides
• Insecticides
• Repellents and attractants

Other Biocidal Products

• Antifouling products
• Embalming and taxidermist fluids
• Other specialist biocidal applications

The exact regulatory requirements depend on the specific active substance/Product Type combination and intended use.

Product Authorization Requirements

Approval of an active substance does not automatically mean that every product containing that substance can be freely marketed.

A biocidal product generally requires authorization before it can be made available on the market or used, subject to applicable transitional provisions. Authorization can occur through national authorization, mutual recognition or Union authorization routes.

Companies should determine which route is appropriate based on:

• Target Member States
• Product Type
• Active substance status
• Product formulation
• Intended use
• User category
• Risk profile
• Existing authorizations

National authorization applications are submitted through R4BP 3, and mutual recognition can be used to extend an authorization to additional Member States under the applicable procedures.

Review Programme and Transitional Compliance

The BPR also interacts with the Review Programme, which covers existing active substances being evaluated for approval.

Where an active substance is included in the Review Programme but has not yet received an approval decision, biocidal products may continue to be placed on the market and used subject to applicable national legislation and transitional provisions.

Companies should therefore avoid assuming that:

“Not yet approved” = “automatically prohibited.”

Instead, they should determine whether the relevant active substance/Product Type combination is:

• Approved
• Under the Review Programme
• Included in Annex I
• Subject to non-approval
• Awaiting regulatory action
• Covered by transitional provisions

Who Should Pay Attention?

Supplier and Supply Chain Controls

Biocides compliance often depends on information received from upstream suppliers.

A strong supplier-control programme should include:

• Active substance identity
• CAS/EC information
• Product Type
• Approval status
• Approval conditions
• Article 95 evidence
• Composition information
• Safety documentation
• Supplier declarations
• Authorization information
• Change notifications
• Regulatory status updates

Companies should not rely solely on statements such as:

• “BPR compliant”

or

• “EU approved.”

The relevant question is whether the specific active substance, Product Type, formulation, supplier and intended use satisfy the applicable BPR requirements.

Impact on Manufacturers and Importers

Manufacturers may need to:

• Review active substances
• Confirm Product Types
• Verify approval status
• Check Article 95 suppliers
• Assess product authorization
• Review formulations
• Evaluate treated-article obligations
• Update labels and claims
• Maintain technical documentation
• Monitor regulatory changes

Importers may need to:

• Screen imported biocidal products
• Confirm active-substance status
• Verify Article 95 requirements
• Confirm product authorization
• Review supplier declarations
• Assess treated articles
• Maintain compliance evidence
• Establish change-notification procedures

The objective should be a documented, risk-based BPR compliance strategy covering the entire supply chain.

Frequently Asked Questions

1. What is the EU Biocidal Products Regulation?

BPR is the EU regulatory framework governing the making available on the market and use of biocidal products and certain treated articles. It also establishes requirements for active-substance approval and product authorization.

2. Does an approved active substance automatically authorize a product?

No. Active-substance approval and biocidal-product authorization are separate regulatory steps.

3. What is Article 95?

Article 95 establishes requirements concerning suppliers of relevant active substances and products. Biocidal products generally cannot be made available on the EU market unless the relevant substance or product supplier is included on the Article 95 list for the applicable Product Type.

4. What is a treated article?

A treated article is an article treated with or intentionally incorporating a biocidal product, but which does not have a primary biocidal function. Such articles are subject to specific BPR requirements.

5. Are all chemicals used for preservation regulated as biocides?

Not necessarily. The regulatory classification depends on the intended function, claims, active substance and applicable BPR scope and Product Type.

6. Can products containing active substances under the Review Programme still be marketed?

Potentially yes, subject to applicable transitional provisions and national legislation. Companies should verify the specific active substance/Product Type status rather than if pending approval means prohibition.

7. Do treated articles require labelling?

Certain treated articles require labelling, including where a biocidal claim is made or where labelling is required by the active-substance approval conditions.

8. Does the BPR apply to companies outside the EU?

Yes. Non-EU manufacturers and suppliers can be affected where their products, active substances or treated articles are placed on the EU/EEA market.

Conclusion

The EU Biocidal Products Regulation creates a comprehensive compliance framework covering active substances, biocidal products, suppliers, authorizations and treated articles.

For manufacturers, importers and distributors, compliance should not be limited to checking whether a chemical is “approved.” Companies should evaluate the complete regulatory chain, including Product Type, active-substance status, Article 95 listing, product authorization, treated-article requirements, labelling, claims and supply-chain documentation.

With regulatory decisions and active-substance statuses continuing to evolve, companies should maintain ongoing monitoring rather than treating BPR compliance as a one-time assessment.

A proactive approach can help businesses identify regulatory gaps, protect market access and support compliant product development across the EU/EEA.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions can support companies with:

• EU Biocides regulatory assessments
• BPR compliance reviews
• Active substance status assessments
• Product Type classification
• Article 95 assessments
• Biocidal product authorization support
• Treated-article assessments
• Review Programme assessments
• Supplier compliance assessments
• Formulation and composition reviews
• Biocidal claim assessments
• Labelling and regulatory documentation
• Import compliance assessments
• Regulatory gap assessments
• Product lifecycle management
• Regulatory intelligence

Our approach helps manufacturers, importers, suppliers and product owners understand their BPR obligations, identify regulatory gaps and develop practical strategies for maintaining EU market compliance.